The prediction that the only Wnt capable of binding to SMO with at least moderate affinity is Wnt3a is quite interesting, considering that both of these proteins are implicated in numerous cancer types [37,38,39], albeit studied in distinct signalling contexts. Here, WNT3A is linked to cancer.